1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 15th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Central Autonomic Network Disturbance in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Pilot Study, 2021, Zinn, Zinn and Jason

Discussion in 'ME/CFS research' started by Andy, Jun 30, 2021.

  1. Andy

    Andy Committee Member

    Messages:
    21,950
    Location:
    Hampshire, UK
    ABSTRACT

    Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating disease of the central nervous system known to be associated with multiple behavioral symptoms (fatigue, low stamina, dizziness, etc.) combined with autonomic nervous system (ANS) dysfunction, thus implicating the central autonomic network (CAN). Post-exertional malaise (PEM) is a core feature of ME/CFS, characterized by a pathological reduction in stamina in response to performing minor physical or mental tasks, often lasting at least 24 hours. Exact low-resolution electromagnetic tomography (eLORETA) allows non-invasive investigation of cortical regions of interest that may contribute to better understanding of the role of the brain disturbances in behavioral manifestations of PEM. This pilot study therefore aimed to use eLORETA to characterize changes in current density in cortical structures related to the CAN following submaximal isometric handgrip exercise in 7 patients with ME/CFS and 6 neurotypical healthy controls (HCs). Resting EEG was recorded at pre-, post- handgrip, and 24 hours later. Findings showed that significant differences occurred immediately post-test, which were most pronounced after 24 hours, particularly in the low alpha (8-10 Hz) and low beta (13-18 Hz) frequency sub-bands. Together, the present findings offer support for EEG source localization techniques to investigate PEM. If confirmed, this study could provide a useful instrument for functional diagnosis and evaluation of treatment outcomes.

    Open access, https://www.neuroregulation.org/article/view/21387
     
    Yessica, DokaGirl, Simon M and 8 others like this.
  2. Andy

    Andy Committee Member

    Messages:
    21,950
    Location:
    Hampshire, UK
    Err, what????

    "Post-exertional malaise (PEM) is a core feature of ME/CFS, characterized by a pathological reduction in stamina in response to performing minor physical or mental tasks, often lasting at least 24 hours."
     
    Mithriel, DokaGirl, Simon M and 10 others like this.
  3. Ravn

    Ravn Senior Member (Voting Rights)

    Messages:
    2,062
    Location:
    Aotearoa New Zealand
    I interpret this as meaning that minor exertion induces PEM, and that with PEM your ability to do stuff is even less than usual (e.g. on day 2 of a repeat CPET). Which, while somewhat limited, is a fair enough description and makes sense in the context of what they're looking at in this study.

    As for the study itself, I don't know anything about eLORETA or EEG, or how well or how badly they've applied the techniques here - but I am pleased somebody's looking at less exhausting ways than CPET to study the aftereffects of exertion.
     
  4. Andy

    Andy Committee Member

    Messages:
    21,950
    Location:
    Hampshire, UK
    The problem, for me, is that you, as a knowledgeable and sadly experienced ME patient, have had to interpret that - I understand that, maybe, they have emphasised an aspect of PEM that is most relevant to their study, but to say that it is the characteristic feature of PEM is concerning to me. I would not want any researchers new to the ME field reading this paper and taking away the 'fact' that the main issue that PEM causes is a reduction in stamina.
     
    Simone, Mithriel, Ravn and 5 others like this.
  5. Trish

    Trish Moderator Staff Member

    Messages:
    52,315
    Location:
    UK
    Is it just me, or is the abstract ambiguous.

    The EEG/eLORETA was used before, after and 24 hours after the exercise. Significant differences are reported, but it's not made clear whether that is between patients and controls, or between times of recording for patients.

    Edit: I've looked at the PDF. It seems it's a between group difference.
     
    Last edited: Jul 1, 2021
    Mithriel, Ravn, Michelle and 4 others like this.

Share This Page